Literature DB >> 11916908

The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity.

Michael Gaster1, Ingrid Petersen, Kurt Højlund, Pernille Poulsen, Henning Beck-Nielsen.   

Abstract

The most well-described defect in the pathophysiology of type 2 diabetes is reduced insulin-mediated glycogen synthesis in skeletal muscles. It is unclear whether this defect is primary or acquired secondary to dyslipidemia, hyperinsulinemia, or hyperglycemia. We determined the glycogen synthase (GS) activity; the content of glucose-6-phosphate, glucose, and glycogen; and the glucose transport in satellite cell cultures established from diabetic and control subjects. Myotubes were precultured in increasing insulin concentrations for 4 days and subsequently stimulated acutely by insulin. The present study shows that the basal glucose uptake as well as insulin-stimulated GS activity is reduced in satellite cell cultures established from patients with type 2 diabetes. Moreover, increasing insulin concentrations could compensate for the reduced GS activity to a certain extent, whereas chronic supraphysiological insulin concentrations induced insulin resistance in GS and glucose transport activity. Our data suggest that insulin resistance in patients with type 2 diabetes comprises at least two important defects under physiological insulin concentrations: a reduced glucose transport under basal conditions and a reduced GS activity under acute insulin stimulation, implicating a reduced glucose uptake in the fasting state and a diminished insulin-mediated storage of glucose as glycogen after a meal.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916908     DOI: 10.2337/diabetes.51.4.921

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  45 in total

1.  Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma co-activator 1.

Authors:  L Al-Khalili; M Forsgren; K Kannisto; J R Zierath; F Lönnqvist; A Krook
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

2.  Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods.

Authors:  Tine E Thingholm; Steffen Bak; Henning Beck-Nielsen; Ole N Jensen; Michael Gaster
Journal:  Mol Cell Proteomics       Date:  2011-06-22       Impact factor: 5.911

3.  Artemisia dracunculus L. extract ameliorates insulin sensitivity by attenuating inflammatory signalling in human skeletal muscle culture.

Authors:  B Vandanmagsar; K R Haynie; S E Wicks; E M Bermudez; T M Mendoza; D Ribnicky; W T Cefalu; R L Mynatt
Journal:  Diabetes Obes Metab       Date:  2014-03-10       Impact factor: 6.577

4.  Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.

Authors:  Theodore P Ciaraldi; Vanita Aroda; Sunder Mudaliar; R Jeffrey Chang; Robert R Henry
Journal:  J Clin Endocrinol Metab       Date:  2008-10-14       Impact factor: 5.958

5.  Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients.

Authors:  D Cozzone; S Fröjdö; E Disse; C Debard; M Laville; L Pirola; H Vidal
Journal:  Diabetologia       Date:  2008-01-18       Impact factor: 10.122

6.  Myotoxic reactions to lipid-lowering therapy are associated with altered oxidation of fatty acids.

Authors:  Paul S Phillips; Theodore P Ciaraldi; Dong-Lim Kim; M Anthony Verity; Tanya Wolfson; Robert R Henry
Journal:  Endocrine       Date:  2008-12-03       Impact factor: 3.633

7.  Impaired cell surface expression of HLA-B antigens on mesenchymal stem cells and muscle cell progenitors.

Authors:  Adiba Isa; Jan O Nehlin; Hardee J Sabir; Tom E Andersen; Michael Gaster; Moustapha Kassem; Torben Barington
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

8.  Physical activity is associated with retained muscle metabolism in human myotubes challenged with palmitate.

Authors:  C J Green; T Bunprajun; B K Pedersen; C Scheele
Journal:  J Physiol       Date:  2013-06-17       Impact factor: 5.182

9.  Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells.

Authors:  D Cozzone; C Debard; N Dif; N Ricard; E Disse; J Vouillarmet; R Rabasa-Lhoret; M Laville; D Pruneau; J Rieusset; E Lefai; H Vidal
Journal:  Diabetologia       Date:  2006-02-16       Impact factor: 10.122

10.  GSK-3beta and control of glucose metabolism and insulin action in human skeletal muscle.

Authors:  T P Ciaraldi; L Carter; S Mudaliar; R R Henry
Journal:  Mol Cell Endocrinol       Date:  2009-06-06       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.